• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPHER METHKE GMBH & CO. KG PROGAV VALVE; HYDROCEPHALUS VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPHER METHKE GMBH & CO. KG PROGAV VALVE; HYDROCEPHALUS VALVES Back to Search Results
Model Number FX410T
Device Problem Obstruction of Flow (2423)
Patient Problem Failure of Implant (1924)
Event Date 11/21/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Implant date: (b)(6) 2008 (day unknown).When additional information is received a follow up report will be submitted.
 
Event Description
It was reported by the healthcare professional "10y 7m po overdrainage of the valve.Explanted.".
 
Manufacturer Narrative
All parameters have been inspected and approved during the manufacturing process.All parameters have been assessed as meeting specifications.A deformation of the outer housing of the progav was observed through the visual inspection.The progav housing was subsequently measured and confirmed the presence of a deformation.The housing deformation measured at -0.720mm, outside the tolerance of 0+/-0.02mm.A permeabiltiy test has shown that the progav valve is permeable.The progav was tested and is adjustable to all specific pressures.The brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances.To test the opening pressure, we used a miethke computer controlled testing apparatus, which simulates a cerebrospinal fluid flow.The test has shown that the progav is not operating within acceptable tolerances.We have dismanteled the valve.Inside the valve we have found a slight build up of substances (likely protein).Based on out investigation, we are unable to substantiate the claim of over-drainage.In contrast, our investigation shows that the valve is operating in an under-drainage state, likely due to the deposits observed inside the valve.As described in our literature, even a small amount of blood or protein can lead to a temporary blockage and could be responsible for the suspected malfunction.This is one of the known, inevitable risks of hc-therapy by shunt implants.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV VALVE
Type of Device
HYDROCEPHALUS VALVES
Manufacturer (Section D)
CHRISTOPHER METHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8157938
MDR Text Key130165066
Report Number3004721439-2018-00295
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K161853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 12/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/12/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2012
Device Model NumberFX410T
Device Catalogue NumberFX410T
Device Lot Number4501070419
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/26/2018
Distributor Facility Aware Date12/11/2018
Device Age11 YR
Date Manufacturer Received12/11/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age10 YR
Patient Weight48
-
-